Stratos Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,306
Closed -$196K 1636
2025
Q3
$196K Buy
18,306
+445
+2% +$4.37K ﹤0.01% 1481
2025
Q2
$173K Sell
17,861
-4,014
-18% -$41.4K ﹤0.01% 1352
2025
Q1
$326K Sell
21,875
-9,838
-31% -$151K 0.01% 1049
2024
Q4
$473K Buy
31,713
+16,247
+105% +$265K 0.01% 958
2024
Q3
$296K Buy
15,466
+2,043
+15% +$42.3K ﹤0.01% 1157
2024
Q2
$278K Sell
13,423
-44
-0.3% -$874 ﹤0.01% 1115
2024
Q1
$253K Buy
13,467
+301
+2% +$5.17K ﹤0.01% 1171
2023
Q4
$190K Buy
+13,166
New +$179K ﹤0.01% 1281
2022
Q3
Sell
-18,155
Closed -$613K 1201
2022
Q2
$613K Sell
18,155
-1,279
-7% -$44.8K 0.02% 654
2022
Q1
$679K Buy
19,434
+131
+0.7% +$4.48K 0.02% 686
2021
Q4
$588K Buy
19,303
+12,866
+200% +$419K 0.01% 751
2021
Q3
$211K Sell
6,437
-373
-5% -$11.9K 0.01% 1082
2021
Q2
$206K Buy
+6,810
New +$224K 0.01% 1109

Other funds holding OGN

Stratos Wealth Partners's OGN Position: Q4 2025 in Review

Stratos Wealth Partners sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 18,306 shares — an estimated $196K sold.

Stratos Wealth Partners first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $679K in Q1 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Stratos Wealth Partners reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Stratos Wealth Partners sold 18,306 Organon & Co shares in Q4 2025, an estimated $196K.
  • Stratos Wealth Partners first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Stratos Wealth Partners's Organon & Co position peaked at $679K in Q1 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Stratos Wealth Partners's 13F filing for Q4 2025, filed 20 Jan 2026.